{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:11:53Z","timestamp":1770966713179,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.schres.2017.08.012","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T21:45:44Z","timestamp":1503524744000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Rapid vs. slow antipsychotic initiation in schizophrenia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8844-4786","authenticated-orcid":false,"given":"Hiroyoshi","family":"Takeuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadhana","family":"Thiyanavadivel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofer","family":"Agid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Remington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2017.08.012_bb0005","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.jcp.0000085406.08426.a8","article-title":"Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation","volume":"23","author":"Baker","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2017.08.012_bb0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.08.012_bb0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hup.844","article-title":"Rapid dose initiation of quetiapine for the treatment of acute schizophrenia and schizoaffective disorder: a randomised, multicentre, parallel-group, open study","volume":"22","author":"Boidi","year":"2007","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.schres.2017.08.012_bb0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00213-002-1344-3","article-title":"Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study","volume":"166","author":"Casey","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2017.08.012_bb0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1176\/ajp.136.3.273","article-title":"Overview: efficacy and safety of the rapid neuroleptization method with injectable haloperidol","volume":"136","author":"Donlon","year":"1979","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.08.012_bb0030","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/gps.2737","article-title":"Short-term safety and pharmacokinetic profile of asenapine in older patients with psychosis","volume":"27","author":"Dubovsky","year":"2012","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.schres.2017.08.012_bb0035","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s40263-016-0352-5","article-title":"Antipsychotic drug-induced somnolence: incidence, mechanisms, and management","volume":"30","author":"Fang","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.schres.2017.08.012_bb0040","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.08.012_bb0045","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2165\/11591710-000000000-00000","article-title":"Antipsychotic pharmacotherapy and orthostatic hypotension","volume":"25","author":"Gugger","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.schres.2017.08.012_bb0050","series-title":"ECDEU Assessment Manual for Psychopharmacology, US Department of Health, Education, and Welfare Publication ADM 76-338","author":"Guy","year":"1976"},{"key":"10.1016\/j.schres.2017.08.012_bb0055","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.kjms.2011.06.014","article-title":"Rapid initiation of quetiapine well tolerated as compared with the conventional initiation regimen in patients with schizophrenia or schizoaffective disorders","volume":"27","author":"Hsiao","year":"2011","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.schres.2017.08.012_bb0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/acps.12241","article-title":"Effectiveness and safety of rapid clozapine titration in schizophrenia","volume":"130","author":"Ifteni","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2017.08.012_bb0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2017.08.012_bb0070","doi-asserted-by":"crossref","first-page":"887","DOI":"10.4088\/JCP.v66n0711","article-title":"Risperidone dosing pattern and clinical outcome in psychosis: an analysis of 1713 cases","volume":"66","author":"Kim","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2017.08.012_bb0075","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s40261-012-0002-8","article-title":"A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400mg\/day versus 800mg\/day in patients with acute exacerbations of schizophrenia","volume":"32","author":"Lee","year":"2012","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.schres.2017.08.012_bb0080","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.WNF.0000220819.71231.96","article-title":"A single-blind, randomized comparison of olanzapine at a starting dose of 5mg versus 20mg in acute schizophrenia","volume":"29","author":"Mauri","year":"2006","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.schres.2017.08.012_bb0085","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4088\/JCP.12m07992","article-title":"Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics","volume":"74","author":"McEvoy","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2017.08.012_bb0090","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.schres.2017.08.012_bb0095","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.schres.2017.08.012_bb0100","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4088\/JCP.v68n0307","article-title":"Rapid versus conventional initiation of quetiapine in the treatment of schizophrenia: a randomized, parallel-group trial","volume":"68","author":"Pae","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2017.08.012_bb0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/schbul\/sbq042","article-title":"Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons","volume":"38","author":"Rummel-Kluge","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2017.08.012_bb0110","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-0028-1112134","article-title":"Switching to aripiprazole in outpatients with schizophrenia experiencing insufficient efficacy and\/or safety\/tolerability issues with risperidone: a randomized, multicentre, open-label study","volume":"42","author":"Ryckmans","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.schres.2017.08.012_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.schres.2017.08.012_bb0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.jcp.0000168486.14516.7c","article-title":"Rapid dose escalation with quetiapine","volume":"25","author":"Smith","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2017.08.012_bb0125","first-page":"862","article-title":"Immediate vs gradual discontinuation in antipsychotic switching: a systematic review and meta-analysis","volume":"43","author":"Takeuchi","year":"2017","journal-title":"Schizophr. Bull."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417304875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417304875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T06:50:41Z","timestamp":1535439041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417304875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":25,"alternative-id":["S0920996417304875"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.08.012","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid vs. slow antipsychotic initiation in schizophrenia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}